P
Disturbing the peace at Peaceful Peptides
I picture the disturbance first: an injured stomach, an inflamed bowel, a cell with work to do. Recovery gives these experiments their question.
1 · BPC-157
Damaged stomach lining, new vessels and a very small human safety pilot.
Visit the stomach chapter →2 · KPV
Inflamed bowel tissue, delivery experiments and wounds on rabbit corneas.
Follow the bowel experiments →3 · NAD+
A busy cell’s coenzyme supply, blood measurements and muscle insulin sensitivity.
Examine the metabolic findings →4 · GHK-Cu
Skin renewal, copper passage and a hair trial with more than one ingredient.
Look at the skin work →Stomach-ulcer experiments
The peaceful name runs into trouble immediately. In a 2004 study of gastric ulcers in rats, BPC-157 reduced ulcer area and accelerated healing. The reported changes included rebuilding the glandular lining and forming repair tissue. Those are quite physical events. A stomach has been damaged; the experiment examines what happens afterward.
Starting with an ulcer rather than a wellness promise suits my curiosity. Recovery sounds soothing until the paper describes the work involved. It also becomes much more particular: a smaller ulcer in a rat stomach gives a definite result to consider, while a general promise of feeling restored can stretch almost indefinitely.
The human record is much thinner. A 2025 review counted only three small BPC-157 pilot studies and described the lack of rigorous large trials. I’d support further investigation of those animal repair findings. Calling the human treatment question settled would take a leap the research has yet to make.
Inflammation, fuel and rebuilding
The other compounds introduce different disturbances and demands. In cell cultures and mouse bowel experiments, KPV reduced inflammatory signalling and colitis severity. NAD+ is involved in the cell’s ordinary energy transactions as well as DNA repair and enzymes competing for the same supply. With GHK-Cu, the interest turns to skin’s supporting material and its renewal.
There is activity in this version of peace. Tissue may need to rebuild; a cell may need to meet demand; an experimental bowel may show less inflammation. I’m wary of merging all those jobs into a single idea of wellness. Each has a different starting condition and a different way to tell whether anything improved.
NAD+ makes the comparison especially useful because it is a coenzyme rather than a peptide. Even this small collection resists a tidy family story.
The aftermath in people
A human NMN trial offers a more complicated picture than a simple success or failure. In postmenopausal women with prediabetes, muscle insulin sensitivity improved over 10 weeks, while body composition and HbA1c stayed unchanged. HbA1c is the longer-term blood-sugar measurement. I’d choose that uneven outcome over a sweeping rejuvenation claim. It gives the next experiment somewhere precise to go.
The compound chapters below follow the stomach, bowel, muscle and skin work in turn. The comparison puts the outcomes together; the reading list contains the original experiments and reviews. Human benefit, long-term safety and medical approval remain separate questions throughout.